ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 56 filers reported holding ONCOCYTE CORP in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $15 | -99.8% | 65,123 | +516.8% | 0.00% | 0.0% |
| Q3 2022 | $8,000 | -57.9% | 10,558 | -49.1% | 0.00% | -50.0% |
| Q2 2022 | $19,000 | -78.7% | 20,741 | -44.0% | 0.00% | -80.0% |
| Q4 2020 | $89,000 | +74.5% | 37,030 | +39.7% | 0.01% | +66.7% |
| Q2 2020 | $51,000 | 0.0% | 26,504 | +16.2% | 0.01% | +20.0% |
| Q4 2019 | $51,000 | -55.3% | 22,801 | -21.1% | 0.01% | -16.7% |
| Q1 2019 | $114,000 | – | 28,883 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 23,353,697 | $17,048,000 | 1.30% |
| AWM Investment Company, Inc. | 7,746,557 | $5,655,000 | 0.86% |
| PURA VIDA INVESTMENTS, LLC | 18,056,274 | $13,181,000 | 0.76% |
| Defender Capital, LLC. | 2,551,980 | $1,883,000 | 0.74% |
| Penbrook Management LLC | 563,350 | $411,000 | 0.35% |
| ACT CAPITAL MANAGEMENT, LLC | 330,000 | $241,000 | 0.33% |
| CALIBER WEALTH MANAGEMENT, LLC | 75,120 | $55,000 | 0.04% |
| Fort Sheridan Advisors LLC | 135,000 | $99,000 | 0.03% |
| Orbimed Advisors | 1,882,768 | $1,374,000 | 0.03% |
| WEALTH EFFECTS LLC | 51,000 | $37,000 | 0.02% |